By Canadian Press

Allergan expands recall of Biocell textured breast implants following Canadian ban

Jul 24, 2019 | 7:35 AM

TORONTO — Allergan PLC says it’s voluntarily recalling Biocell textured breast implants and tissue expanders worldwide, a move that follows Canada’s suspension of the product’s licences due to potential risks from cancer.

The international pharmaceutical company says in a press release from Dublin, Ireland that it’s issuing the recall as a precaution following recently updated safety information from the U.S. Food and Drug Administration.

However, Health Canada announced in May that it had suspended the licences for Biocell macro-textured breast implants after completing a safety review that was launched two years ago.

The Canadian agency said at the time that it had been notified of 22 confirmed Canadian cases of breast-implant-associated lymphoma involving Allergan’s Biocell breast textured implants, but no cases with smooth implants.

Allergan told Health Canada at the time it would voluntarily recall unused Biocell devices from the Canadian market.

Holiday festivities

Ponoka's Enchanted Forest Festival of Trees begins next week

1h ago

Holiday charity

Pattison Media raises $28,000 for The Outreach Centre during Day of Holiday Hope radiothon

2h ago

Ending hunger

Canadian Foodgrains Bank highlights work at event in Red Deer

Nov 15, 2024

The company now says healthcare providers worldwide should immediately stop using Biocell saline-filled and silicone-filled textured breast implants and tissue expanders, and unused devices are being recalled from all markets.

The Canadian Press